Edwards Lifesciences Corp
I · AI-analyse
In het kort
Edwards Lifesciences makes medical devices to treat advanced heart diseases, focusing on transcatheter heart valve replacement (SAPIEN family), valve repair products (PASCAL, EVOQUE), and surgical structural heart solutions (INSPIRIS line) [Company Overview]. They sell through direct sales teams and distributors across the United States, Europe, Japan, and other international markets [Company Overview].
Edwards Lifesciences is a $47.3B medical device company specializing in advanced heart valve replacement and repair products, serving patients with serious cardiovascular diseases [Yahoo Finance]. The company has lagged the S&P 500 significantly over the past year (+7.8% vs. +26.6%), suggesting investor caution despite strong underlying financials [Yahoo Finance]. Recent insider selling activity and a JPMorgan Chase position reduction warrant attention [SEC Form 4] [EODHD].
Edwards is financially robust with excellent margins, zero net debt, and strong cash generation [Yahoo Finance].
Sentinellis-score
9,5/10
Financieel gezond
Marktkapitalisatie
$47,3B
Omzet (12 maanden)
$6,1B
Uitleg
Hoe wij deze cijfers lezen
Begrijpelijke gidsen · geen account nodig
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LezenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LezenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LezenII · Recent nieuws
Wat de koers bewoog
1 bericht · gesorteerd op relevantie
- Macro2026-05-14
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?
Yahoo Finance
Premium · gratis met elk account
The stock trades at a premium 44.4x P/E ratio, which magnifies downside risk if growth disappoints or margins compress [Yahoo Finance]
Risico's
4
Kansen
4
Waarschuwingssignalen
3
Leiding
10
Nog 10 bevindingen in het volledige rapport — gratis met elk account.
Ontgrendel de volledige analyse van Edwards Lifesciences Corp
Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.
- 4 risico's, 4 kansen en 3 waarschuwingssignalen — elk met zijn bron
- Meer dan 100 financiële cijfers met grafieken en vergelijkingen
- Volledige nieuwssamenvattingen met bronlinks
- Directie en beloning
- PDF-export voor offline
III · Vergelijkbare bedrijven
Misschien ook interessant
Zelfde sector · Gezondheidszorg — of vergelijkbare financiële gezondheid
Op je volglijst zetten?